Get the Stockscreener App
3.53
7.95%
+0.26
Pre-market:
3.66
0.13
+3.68%
Myomo Inc stock is currently priced at $3.53, with a 24-hour trading volume of 298.88K.
It has seen a +7.95% increased in the last 24 hours and a +14.24% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $3.31 pivot point. If it approaches the $3.48 resistance level, significant changes may occur.
Previous Close:
$3.27
Open:
$3.28
24h Volume:
298.88K
Market Cap:
$100.56M
Revenue:
$19.24M
Net Income/Loss:
$-8.15M
P/E Ratio:
-4.2024
EPS:
-0.84
Net Cash Flow:
$-6.32M
1W Performance:
+2.62%
1M Performance:
+14.24%
6M Performance:
+182.40%
1Y Performance:
+552.37%
1D Range:
$3.17
$3.62
52W Range:
$0.371
$5.5799
Myomo Inc Stock (MYO) Company Profile
Name
Myomo Inc
Sector
Industry
Phone
617-996-9058
Address
One Broadway, 14th Floor, Cambridge, MA
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-11-20 | Upgrade | ROTH Capital | Neutral → Buy |
| May-27-20 | Initiated | Dougherty & Company | Buy |
| Oct-02-17 | Initiated | H.C. Wainwright | Buy |
Myomo Inc Stock (MYO) Latest News
Myomo Inc Stock (MYO) Financials Data
Myomo Inc (MYO) Revenue 2024
MYO reported a revenue (TTM) of $19.24 million for the quarter ending December 31, 2023, a +23.70% rise year-over-year.
Myomo Inc (MYO) Net Income 2024
MYO net income (TTM) was -$8.15 million for the quarter ending December 31, 2023, a +24.00% increase year-over-year.
Myomo Inc (MYO) Cash Flow 2024
MYO recorded a free cash flow (TTM) of -$6.32 million for the quarter ending December 31, 2023, a +38.92% increase year-over-year.
Myomo Inc (MYO) Earnings per Share 2024
MYO earnings per share (TTM) was -$0.28 for the quarter ending December 31, 2023, a +81.58% growth year-over-year.
About Myomo Inc
Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
0.23%
0.60%
Cap:
|
Volume (24h):